Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action

Type 2 diabetes is a serious problem for developed countries. Prevention of prediabetes progression to type 2 diabetes with the use of natural products appears to a cost-effective solution. Previously we showed that enzymatically digested low molecular weight chitosan-oligosaccharide with molecular...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC complementary and alternative medicine 2014-07, Vol.14 (1), p.272-272, Article 272
Hauptverfasser:	Kim, Jong-Gwan, Jo, Sung-Hoon, Ha, Kyoung-Soo, Kim, Sung-Chul, Kim, Young-Cheul, Apostolidis, Emmanouil, Kwon, Young-In
Format:	Artikel
Sprache:	eng
Schlagworte:	Amylases Analysis Animals Blood Glucose - drug effects Blood sugar Body Weight - drug effects Chitosan - analogs & derivatives Chitosan - pharmacology Diabetes Diabetes Mellitus, Experimental - blood Diabetes Mellitus, Experimental - drug therapy Diabetes Mellitus, Experimental - metabolism Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - prevention & control Eating - drug effects Enzymes Fasting Glucose Glycated Hemoglobin A - metabolism Glycoside Hydrolases - metabolism Hyperglycemia Hyperglycemia - blood Hyperglycemia - drug therapy Hyperglycemia - metabolism Insulin Intestines - enzymology Male Measurement Medical research Medicine, Experimental Mice Mice, Inbred C57BL Mice, Transgenic Nutrition research Oligosaccharides - pharmacology Prediabetic State - blood Prediabetic State - drug therapy Prediabetic State - metabolism Rodents Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!